Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manolo Mugnaini

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Current Opinion in Pharmacology|August 15, 2017
Receptor distribution studiesRenzo Carletti, Stefano Tacconi, Manolo Mugnaini, et al.
The European Journal of Neuroscience|November 15, 2002
Upregulation of [3H]methyllycaconitine binding sites following continuous infusion of nicotine, without changes of alpha7 or alpha6 subunit mRNA: an autoradiography and in situ hybridization study in rat brainManolo Mugnaini, Michela Tessari, Giorgio Tarter, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 3, 2007
The use of knock-out mice unravels distinct roles for mGlu2 and mGlu3 metabotropic glutamate receptors in mechanisms of neurodegeneration/neuroprotectionCorrado Corti, Giuseppe Battaglia, Gemma Molinaro, et al.
Molecular Pharmacology|May 5, 2010
A comparative study of the effects of the intravenous self-administration or subcutaneous minipump infusion of nicotine on the expression of brain neuronal nicotinic receptor subtypesMilena Moretti, Manolo Mugnaini, Michela Tessari, et al.
Brain Research. Brain Research Reviews|June 18, 2005
The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidenceChristian A Heidbreder, Eliot L Gardner, Zheng-Xiong Xi, et al.
Synapse (New York, N.Y.)|October 14, 2003
Dopamine responsiveness to drugs of abuse: A shell-core investigation in the nucleus accumbens of the mouseAlessandro Zocchi, Elena Girlanda, Giorgia Varnier, et al.
Psychopharmacology|July 5, 2015
The novel mu-opioid antagonist, GSK1521498, reduces ethanol consumption in C57BL/6J miceTamzin L Ripley, Sandra Sanchez-Roige, Edward T Bullmore, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 16, 2010
Nicotinic acetylcholine receptors in the mesolimbic pathway: primary role of ventral tegmental area alpha6beta2* receptors in mediating systemic nicotine effects on dopamine release, locomotion, and reinforcementCecilia Gotti, Stefania Guiducci, Vincenzo Tedesco, et al.
British Journal of Pharmacology|January 15, 2011
Stable expression and functional characterization of a human nicotinic acetylcholine receptor with α6β2 properties: discovery of selective antagonistsAnna Maria Capelli, Laura Castelletti, Yu Hua Chen, et al.
Cells|June 25, 2025
Development and In Vitro Characterization of [<sup>3</sup>H]GMC-058 as Radioligand for Imaging Parkinsonian-Related ProteinopathiesAndrea Varrone, Vasco C Sousa, Manolo Mugnaini, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Current Opinion in Pharmacology|August 15, 2017
Receptor distribution studiesRenzo Carletti, Stefano Tacconi, Manolo Mugnaini, et al.
The European Journal of Neuroscience|November 15, 2002
Upregulation of [3H]methyllycaconitine binding sites following continuous infusion of nicotine, without changes of alpha7 or alpha6 subunit mRNA: an autoradiography and in situ hybridization study in rat brainManolo Mugnaini, Michela Tessari, Giorgio Tarter, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 3, 2007
The use of knock-out mice unravels distinct roles for mGlu2 and mGlu3 metabotropic glutamate receptors in mechanisms of neurodegeneration/neuroprotectionCorrado Corti, Giuseppe Battaglia, Gemma Molinaro, et al.
Molecular Pharmacology|May 5, 2010
A comparative study of the effects of the intravenous self-administration or subcutaneous minipump infusion of nicotine on the expression of brain neuronal nicotinic receptor subtypesMilena Moretti, Manolo Mugnaini, Michela Tessari, et al.
Brain Research. Brain Research Reviews|June 18, 2005
The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidenceChristian A Heidbreder, Eliot L Gardner, Zheng-Xiong Xi, et al.
Synapse (New York, N.Y.)|October 14, 2003
Dopamine responsiveness to drugs of abuse: A shell-core investigation in the nucleus accumbens of the mouseAlessandro Zocchi, Elena Girlanda, Giorgia Varnier, et al.
Psychopharmacology|July 5, 2015
The novel mu-opioid antagonist, GSK1521498, reduces ethanol consumption in C57BL/6J miceTamzin L Ripley, Sandra Sanchez-Roige, Edward T Bullmore, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 16, 2010
Nicotinic acetylcholine receptors in the mesolimbic pathway: primary role of ventral tegmental area alpha6beta2* receptors in mediating systemic nicotine effects on dopamine release, locomotion, and reinforcementCecilia Gotti, Stefania Guiducci, Vincenzo Tedesco, et al.
British Journal of Pharmacology|January 15, 2011
Stable expression and functional characterization of a human nicotinic acetylcholine receptor with α6β2 properties: discovery of selective antagonistsAnna Maria Capelli, Laura Castelletti, Yu Hua Chen, et al.
Cells|June 25, 2025
Development and In Vitro Characterization of [<sup>3</sup>H]GMC-058 as Radioligand for Imaging Parkinsonian-Related ProteinopathiesAndrea Varrone, Vasco C Sousa, Manolo Mugnaini, et al.
Pageof 2